7QPT
Botulinum neurotoxin A4 cell binding domain in complex with GD1a oligosaccharide
7QPT の概要
| エントリーDOI | 10.2210/pdb7qpt/pdb |
| 分子名称 | Neurotoxin type A, N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-galactopyranose-(1-4)-beta-D-galactopyranose-(1-4)-beta-D-glucopyranose (3 entities in total) |
| 機能のキーワード | cell binding domain, receptor, oligosaccharide, neurotoxin, toxin |
| 由来する生物種 | Clostridium botulinum |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 103510.82 |
| 構造登録者 | Gregory, K.S.,Acharya, K.R.,Liu, S.M.,Mojanaga, O.O. (登録日: 2022-01-05, 公開日: 2022-03-16, 最終更新日: 2024-11-06) |
| 主引用文献 | Gregory, K.S.,Mojanaga, O.O.,Liu, S.M.,Acharya, K.R. Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside. Toxins, 14:-, 2022 Cited by PubMed Abstract: Botulinum neurotoxins (BoNT) cause the potentially fatal neuroparalytic disease botulism that arises due to proteolysis of a SNARE protein. Each BoNT is comprised of three domains: a cell binding domain (H), a translocation domain (H), and a catalytic (Zn endopeptidase) domain (LC). The H is responsible for neuronal specificity by targeting both a protein and ganglioside receptor at the neuromuscular junction. Although highly toxic, some BoNTs are commercially available as therapeutics for the treatment of a range of neuromuscular conditions. Here we present the crystal structures of two BoNT cell binding domains, H/A4 and H/A5, in a complex with the oligosaccharide of ganglioside, GD1a and GM1b, respectively. These structures, along with a detailed comparison with the previously reported apo-structures, reveal the conformational changes that occur upon ganglioside binding and the interactions involved. PubMed: 35202156DOI: 10.3390/toxins14020129 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






